Ingredients Maltodextrin, Bulking Agent: Microcrystalline Cellulose, Vitamin C (Ascorbic Acid [Hydroxypropylmethylcellulose & Tartaric Acid]), Magnesium Oxide, L-Carnitine Tartrate, Inositol (Carrier: Acacia Gum) Vitamin E (D-Alpha Tocopheryl Acid Succinate) (from Soya ), Maca Extract, Zinc Sulphate, Tablet Coating: (Hydroxypropylmethylcellulose, Glycerin, Colours [Iron Oxides]), Crosslinked Cellulose Gum, Pine Bark Extract, Anti-Caking Agents: Stearic Acid, Magnesium Stearate & Silicon Dioxide, Thiamin (Vitamin B1 as Mononitrate [Carrier: Hydroxypropylmethylcellulose]), Niacin (as Nicotinamide), Ferrous Fumarate, Citrus Bioflavonoids, Pantothenic Acid (as Calcium Salt), Vitamin B6 (Pyridoxine HCl), L-Arginine, Vitamin A (as Acetate [Carriers: Acacia, Starch, Maltodextrin, Antioxidants: DL-Alpha Tocopherol]), Vitamin D3 (Cholecalciferol [Carriers: Acacia, Sucrose, Corn Starch, Medium Chain Triglycerides, Antioxidant: DL-Alpha Tocopherol]), Siberian Ginseng Extract, Riboflavin, Octacosanol (Rice Bran), Copper Sulphate, L-Glutathione, Coenzyme Q10 (CoQ10), Manganese Sulphate, Lycopene Extract, Folic Acid (as Pteroylmonoglutamic Acid), Sodium Selenate, Chromium Trichloride, Biotin, Vitamin B12 (Cyanocobalamin)
Both forms are available depending on the protocol
The absence of tissue growth effects also means AOD-9604 avoids many common side effects of growth hormone therapy including joint pain and swelling from connective tissue proliferation, carpal tunnel syndrome from tissue expansion, edema and fluid retention from protein synthesis and sodium retention, and concerns about growth-promoting effects in individuals with tumor history
Participants saw rapid initial loss through weeks 4 to 12, peak velocity between weeks 12 and 24 (roughly 1.8 pounds per week), gradual slowing between weeks 24 and 36, and a plateau or near-plateau by weeks 44 to 48
